Brief: Aligos Therapeutics Strengthens Senior Leadership Team With The Appointment Of James Hassard As Executive Vice President, Chief Commercial Officer
13/01/2026 13:06
Jan 13 (Reuters) - Aligos Therapeutics Inc ALGS.O: ALIGOS THERAPEUTICS STRENGTHENS SENIOR LEADERSHIP TEAM WITH THE APPOINTMENT OF JAMES HASSARD AS EXECUTIVE VICE PRESIDENT, CHIEF COMMERCIAL OFFICER Source text: ID:nGNXblfSdz Further company coverage: ALGS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aligos Therapeutics
See all newsUS FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatment (updated)
U.S. RESEARCH ROUNDUP-Ciena Corp, Docusign, Snowflake
Brief: Aligos Therapeutics Announces First Participant Dosed In The Phase 1 Study Of Its Potentially Best-In-Class Antisense Oligonucleotide Alg-170675 By Its Partner Amoytop In China
Aligos Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Aligos Therapeutics Q2 net loss narrows on licensing revenue